Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
0.7794
+0.0289 (3.85%)
At close: Oct 30, 2025, 4:00 PM EDT
0.7564
-0.0230 (-2.95%)
Pre-market: Oct 31, 2025, 4:11 AM EDT
Adicet Bio Market Cap
Adicet Bio has a market cap or net worth of $126.03 million as of October 30, 2025. Its market cap has increased by 0.53% in one year.
Market Cap
126.03M
Enterprise Value
16.42M
1-Year Change
0.53%
Ranking
Category
Stock Price
$0.78
Market Cap Chart
Since September 16, 2020, Adicet Bio's market cap has decreased from $301.68M to $126.03M, a decrease of -58.22%. That is a compound annual growth rate of -15.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2025 | 121.36M | 38.86% |
| Dec 31, 2024 | 87.39M | 7.13% |
| Dec 29, 2023 | 81.58M | -78.70% |
| Dec 30, 2022 | 383.09M | -44.04% |
| Dec 31, 2021 | 684.61M | 148.60% |
| Dec 31, 2020 | 275.39M | -8.72% |
| Sep 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 730.33B |
| Johnson & Johnson | 449.57B |
| AbbVie | 397.72B |
| UnitedHealth Group | 321.75B |
| AstraZeneca | 257.84B |
| Novartis AG | 237.42B |
| Novo Nordisk | 232.34B |
| Abbott Laboratories | 216.57B |